Therapeutic Patient Education for Adrenal Insufficiency under COVID-19 Pandemic Conditions.
Journal
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
ISSN: 1439-3646
Titre abrégé: Exp Clin Endocrinol Diabetes
Pays: Germany
ID NLM: 9505926
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
pubmed:
9
8
2020
medline:
17
3
2021
entrez:
9
8
2020
Statut:
ppublish
Résumé
Adrenal insufficiency (AI) requires life-long treatment with glucocorticoid replacement therapy. Over- or under-substitution carries the risk of increased morbidity in the form of side effects or adrenal crises. Glucocorticoid replacement therapy needs to be flexible with dose adaptation in special situations. This could not be managed by medical personnel on a daily basis, but requires an educated patient who has a good knowledge of the disease, understands his medical therapy and is able to perform situational dose adaptation. The rarity of the disease in combination with the need to respond to stressful situations with rapid glucocorticoid dose adjustment underlines that a well-trained patient is crucial for optimal management of the disease.In this literature review we provide background information further clarifying the need of education in patients with AI including the current shortcomings of medical therapy and of the treatment of patients with AI. We outline the aims of therapeutic patient education, present the concept of structured patient education in Germany, and discuss available results of patient group education programs. Furthermore, we propose strategies how therapeutic patient education for adrenal insufficiency can be organized under COVID-19 pandemic conditions.
Identifiants
pubmed: 32767286
doi: 10.1055/a-1217-7208
pmc: PMC8043669
doi:
Substances chimiques
Glucocorticoids
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
241-249Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
Eur J Intern Med. 2015 Jan;26(1):75-6
pubmed: 25498511
Clin Endocrinol (Oxf). 2014 Mar;80(3):319-21
pubmed: 24299429
BMC Endocr Disord. 2019 Dec 2;19(1):129
pubmed: 31791297
Clin Endocrinol (Oxf). 2004 Sep;61(3):367-75
pubmed: 15355454
Dtsch Arztebl Int. 2013 Dec 23;110(51-52):882-8
pubmed: 24529304
Ann Endocrinol (Paris). 2018 Jun;79(3):167-173
pubmed: 29606279
Eur J Endocrinol. 2013 Oct 21;169(6):R165-75
pubmed: 24031090
J Clin Endocrinol Metab. 1991 Jan;72(1):39-45
pubmed: 1986026
Nat Hum Behav. 2020 Jun;4(6):588-596
pubmed: 32499576
Eur J Endocrinol. 2016 Jan;174(1):97-105
pubmed: 26494876
Clin Endocrinol (Oxf). 2018 Jul;89(1):22-29
pubmed: 29617051
Eur J Endocrinol. 2010 Jan;162(1):115-20
pubmed: 19776201
Lancet. 1990 Aug 4;336(8710):285-8
pubmed: 1973979
J Clin Endocrinol Metab. 2015 Feb;100(2):407-16
pubmed: 25419882
J Clin Endocrinol Metab. 2016 Oct;101(10):3691-3699
pubmed: 27490921
Eur J Endocrinol. 2012 Jul;167(1):35-42
pubmed: 22513882
Nat Rev Endocrinol. 2011 Feb;7(2):115-21
pubmed: 21178996
J Clin Endocrinol Metab. 2020 May 1;105(5):
pubmed: 32232480
Clin Endocrinol (Oxf). 2017 Mar;86(3):340-346
pubmed: 27801983
Eur J Endocrinol. 2010 Mar;162(3):597-602
pubmed: 19955259
Endocr Rev. 2010 Jun;31(3):301-42
pubmed: 20086217
Endocr J. 2015;62(5):463-8
pubmed: 25739727
Eur J Intern Med. 2016 Nov;35:e27-e28
pubmed: 27444736
J Spec Pediatr Nurs. 2017 Oct;22(4):
pubmed: 28771930
Lancet Diabetes Endocrinol. 2016 Jul;4(7):569-76
pubmed: 27265184
J Clin Endocrinol Metab. 2009 Dec;94(12):4882-90
pubmed: 19858318
Horm Metab Res. 2017 Aug;49(8):580-588
pubmed: 28351092
J Intern Med. 2014 Feb;275(2):104-15
pubmed: 24330030
J Clin Endocrinol Metab. 2012 Oct;97(10):E1938-42
pubmed: 22872686
J Clin Endocrinol Metab. 2004 Aug;89(8):3679-84
pubmed: 15292287
BMC Endocr Disord. 2012 Jun 13;12:8
pubmed: 22695167
Eur J Endocrinol. 2016 Jun;174(6):791-9
pubmed: 27025241
Endocrine. 2018 May;60(2):355-361
pubmed: 29388043
J Clin Endocrinol Metab. 2014 Dec;99(12):E2715-21
pubmed: 25279502
Clin Endocrinol (Oxf). 2015 Apr;82(4):497-502
pubmed: 25200922
Clin Endocrinol (Oxf). 2008 Nov;69(5):697-704
pubmed: 18727712
J Clin Endocrinol Metab. 2009 Nov;94(11):4216-23
pubmed: 19808848
Clin Endocrinol (Oxf). 2012 Jan;76(1):21-5
pubmed: 21585418
J Clin Endocrinol Metab. 2019 Apr 22;:
pubmed: 31009052
Eur J Endocrinol. 2013 Mar 15;168(4):609-14
pubmed: 23384710
J Clin Endocrinol Metab. 2013 Apr;98(4):1466-75
pubmed: 23457412
Dtsch Med Wochenschr. 2016 Nov;141(24):1740-1742
pubmed: 27903023
J Clin Endocrinol Metab. 2014 Oct;99(10):3668-76
pubmed: 25226291
Eur J Endocrinol. 2020 Jul;183(1):G25-G32
pubmed: 32379699
J Clin Endocrinol Metab. 2016 Feb;101(2):364-89
pubmed: 26760044
Clin Endocrinol (Oxf). 2018 Jul;89(1):30-35
pubmed: 29682773
J Clin Endocrinol Metab. 2006 Dec;91(12):4849-53
pubmed: 16968806
Endocr J. 2003 Dec;50(6):745-52
pubmed: 14709847
Lancet Diabetes Endocrinol. 2020 Jun;8(6):472-473
pubmed: 32334645
Eur J Endocrinol. 2015 Mar;172(3):R115-24
pubmed: 25288693
Eur J Endocrinol. 2013 May 17;169(1):17-22
pubmed: 23636446
Clin Endocrinol (Oxf). 2016 May;84(5):664-71
pubmed: 26641418
Clin Endocrinol (Oxf). 2019 Aug;91(2):256-262
pubmed: 31050815